Bio

Dr. Sachin Kadian is a Postdoctoral Research Scholar in the Joint Department of Biomedical Engineering at the University of North Carolina and North Carolina State University, NC, USA. Prior to this, he was a Postdoctoral Research Assistant at the School of Materials Engineering, Purdue University, USA, and DST, SERB-Overseas Visiting Doctoral Fellow (OVDF) at the Department of Electrical & Computer Engineering, University of Alberta (UofA), Edmonton, Canada supported by Govt. of India & UofA. He earned his Ph.D. from the Department of Polymer and Process Engineering (Major in materials science, nanotechnology, and biomedical engineering) at the Indian Institute of Technology Roorkee, India in 2021. He received his M. Tech. in Biomedical Engineering from the National Institute of Technology (NIT), Kurukshetra in 2016 and B. Tech. in Electronics and Communication Engineering from the University Institute of Engineering and Technology (UIET), Kurukshetra, India in 2014. He has co-authored over ~40 publications in reputed SCI journals and international conferences as well as book chapters and patents.

Based on his Ph.D. research work, he has received 10 awards and recognitions such as outstanding research article, article featured in top 50 most popular articles, best paper award, top-cited article of the journals, three-minute Thesis (3-MT) award, SERB-OVDF etc. His collaborative work has also been highlighted in several news/magazines including Nature India, Atlas of Science, India Today, Times of India, Republic World, The Times Bureau, The Print, Daily News Post India, etc. His research interests include the synthesis and characterization of quantum dots (graphene, sulfur, carbon, perovskites, and zinc oxide), nanomaterials, nanocomposites and their applications in biosensors, photovoltaics, chemosensors, bioimaging and antibacterial agents. Currently, he is working on 3D printed wearable microneedles technology to print new customized designs for the development of next‑generation interstitial fluid sampling, diagnostic, vaccine, drug and cosmeceutical delivery platforms, and next‑generation personalized healthcare, therapeutic and medical devices.